Showing results (701-710 of 881) with videos related to
Sort By:
Pageof 89
The American Journal of Gastroenterology|November 10, 2018
Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort StudyRichard K Sterling, Abdus S Wahed, Wendy C King, et al.Applied and Environmental Microbiology|April 2, 2008
Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and miceKlaus Michalke, Annette Schmidt, Britta Huber, et al.The International Journal on Drug Policy|September 23, 2023
Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomesOluwaseun Falade-Nwulia, Tracy Agee, Sharon M Kelly, et al.American Journal of Infection Control|July 21, 2023
Is neighborhood deprivation index a risk factor for Staphylococcus aureus infections?Geeta Sood, Geoff Dougherty, John Martin, et al.The Journal of Infectious Diseases|May 15, 2020
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune ActivationDonald D Anthony, Mark S Sulkowski, Laura M Smeaton, et al.Gastroenterology|May 8, 2004
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled studyNezam H Afdhal, Douglas T Dieterich, Paul J Pockros, et al.Hepatology (Baltimore, Md.)|June 21, 2019
Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected AdultsRichard K Sterling, Wendy C King, Abdus S Wahed, et al.AIDS (London, England)|September 24, 2009
Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitutionAshwin Balagopal, Stuart C Ray, Ruben Montes De Oca, et al.Journal of Viral Hepatitis|December 10, 2016
Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirinS Alqahtani, R Ozaras, V Isakov, et al.European Journal of Gastroenterology & Hepatology|June 6, 2014
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infectionAdrian M Di Bisceglie, Mark Sulkowski, Ed Gane, et al.Pageof 89